Clinical Trials Directory

Trials / Completed

CompletedNCT05785429

The Effect of Colchicine on Food-related Effort-based Decision Making in Brain and Behaviour in Overweight and Obesity

The Effect of Colchicine on Food-related Effort-based Decision Making in Brain and Behaviour in Overweight and Obesity: the FLAIR-i Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Donders Centre for Cognitive Neuroimaging · Academic / Other
Sex
Female
Age
18 Years – 59 Years
Healthy volunteers
Accepted

Summary

The main objective of the FLAIR-i study is to study the causal role of inflammation in affecting effort-based decision making in brain and behaviour in overweight and obesity, by comparing the effect of the anti-inflammatory agent colchicine vs. placebo.

Detailed description

Obesity is a major health problem worldwide and is characterized by increases in low-grade, systemic inflammation. Outside the field of obesity, increases in inflammation have been related to loss of motivation and effortful behaviour, which can be objectively measured with effort-based decision making in brain and behaviour. Here, the investigators hypothesise that low-grade inflammation is causing altered striatal brain responses and effortless 'fast food' choices in overweight and obesity. The objective of this study is to study the causal role of inflammation in affecting effort-based decision making in brain and behaviour in overweight and obese participants, by comparing the effect of the anti-inflammatory agent colchicine vs. placebo. In addition, it will be investigated whether this primary objective translates to more ecologically valid measures/settings.

Conditions

Interventions

TypeNameDescription
DRUGColchicine 0.5 MGParticipant in the intervention group receive one tablet of 0.5mg colchicine per day for 12 weeks.
DRUGPlaceboParticipants in the intervention group receive one tablet of placebo per day for 12 weeks.

Timeline

Start date
2022-08-02
Primary completion
2025-01-20
Completion
2025-01-20
First posted
2023-03-27
Last updated
2025-09-02

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05785429. Inclusion in this directory is not an endorsement.